Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 321-327

  Turett, Glenn S ^a,b   Blum, Steve ^a   Fazal, Barkat A ^a   Justman, Jessica E ^a   Telzak, Edward E ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CHILD; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEROPREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032813974     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520209     Document Type: Article

References (44)

1. 1. Centers for Disease Control and Prevention. Defining the health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep 1996;45(RR-1):1-20.
2. 2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
3. 3. Friedland IR, Shelton S, Paris M, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1993;12:196-200.
4. 4. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993; 168:1532-6.
5. 5. Thornsberry C, Brown SD, Yee YG, Bouchillon SK, Masler JF, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in U.S.; effect on susceptibility to oral cephalosporins. Infections in Medicine 1993;10(suppl);15-24.
6. 6. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:18331-5.
7. 7. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 1996;275: 194-8.
8. 8. Centers for Disease Control and Prevention. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae - New York City. MMWR Morb Mortal Wkly Rep 1997;46:297-9.
9. 9. Butler JC, Hoffman J, Cetron MS, Elliot JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis 1996;174:986-93.
10. 10. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med 1995;99(suppl 6B):3S-7S.
11. 11. Istre GR, Tarpay M, Anderson M, et al. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156:732-5.
12. 12. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
13. 13. Raz R, Elhanan G, Inon A. Adult pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis 1997;24:1164-8.
14. 14. Frankel RE, Virata M, Hardalo C, et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996;23:577-84.
15. 15. Meynard JL, Barbut F, Blum L, et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin from patients infected with human immunodeficiency virus. Clin Infect Dis 1996;22:437-40.
16. 16. Turett GS, Shaihk M, Akram JM, et al. Pneumococcal bacteremia at an inner-city hospital during a three year period [abstract no. 268]. In: Proceedings of the 33rd annual meeting of the Infectious Diseases Society of America (San Francisco). Alexandria, VA: Infectious Diseases Society of America, 1995.
17. 17. Simberkoff MS, Sadr WE, Schiffmen G, Rahal JJ. Streptococcus pneumoniae infections and bacteremia in patients with acquired immunodeficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984;130:1174-6.
18. 18. Polsky B, Gold JWM, Whimbey E. et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:38-41.
19. 19. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987;82:900-6.
20. 20. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162:1012-7.
21. 21. Rodriguez-Barradas MC, Musher DM, Hamill RJ, Dowell M, Bagwell JT, Sanders CV. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis 1992;14:192-9.
22. 22. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993;167:49-56.
23. 23. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51.
24. 24. Garcia-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vincente T, Bouza B. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992;152: 1808-12.
25. 25. Ernst J, Amaral L, Janseen R. Seroprevalence rates of HIV infection at the Bronx-Lebanon Hospital Center, 1988 1991. In: Program and abstracts of the 8th International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland, 1992.
26. 26. Watanakunakorn C, Greifenstein A, Stroh K, et al. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 1993;103:1152-6.
27. 27. Marfin AA, Sporrer J, Moore PS, et al. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest 1995;107:457-62.
28. 28. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82:1513-6.
29. 29. Afessa B, Greaves WL, Frederick WR. Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis 1995;21:345-51.
30. 30. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60: 759-76.
31. 31. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
32. 32. Cortese MM, Wolff M, Almeido-Hill J, et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1993;152:2277-82.
33. 33. Davidson M, Parkinson AJ, Bulkow LR, et al. The epidemiology of invasive pneumucoccal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J Infect Dis 1994;170:368-76.
34. 34. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumaniae in Atlanta. N Engl J Med 1995;333:481-6.
35. 35. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
36. 36. Mylotte JM, Bean TR Jr. Comparison of community-acquired and nosocomial pneumococcal bacteremia. Am Rev Respir Dis 1981;123:265-8.
37. 37. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia-mortality in acquired immunodeficiency syndrome. Chest 1992;101: 150-5.
38. 38. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
39. 39. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453-60.
40. 40. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons age ≥65 years. MMWR Morb Mortal Wkly Rep 1995;49:513-5.
41. 41. Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged ≥65 years - United States 1995. Morb Mortal Wkly Rep 1997;46:913-9.
42. 42. Huang KL, Ruben FL, Rinaldo CR, et al. Antibody responses alter influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987;257:2047-50.
43. 43. Rodriguez-Barradas MC, Mosher DM, Lahart C, et al. Antibody to capsular polysaccharide of Streptococcus pneumoniae after vaccination of human immunodeficiency virus infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992;165:553-6.
44. 44. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.